Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Sexual dysfunction associated with major depressive disorder and antidepressant treatment.

Expert opinion on drug safety - 1 Oct 2014

Clayton Anita H, El Haddad Saria, Iluonakhamhe Josepha-Pearl, Ponce Martinez Caridad, Schuck Alexandra Elizabeth

Abstract excerpt

INTRODUCTION: There is a well-established relationship between sexual functioning and quality of life. Depression can cause sexual dysfunction (SD) and its treatment can often lead to restoration of sexual functioning. Use of antidepressants has also been associated with SD, with implications for treatment compliance and creation of further distress for the patient. AREAS COVERED: This review evaluates available...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antidepressive Agents
Share to Depressive Disorder, Major

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Medication Adherence

Share to Practice Guidelines as Topic

Share to Psychiatric Status Rating Scales

Share to Quality of Life

Source

Identifiers

PMID: 25148932
DOI: 10.1517/14740338.2014.951324

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Sexual dysfunction associated with major depressive disorder and antidepressant treatment.PMID 25148932Read ↗

Female sexual dysfunction in patients with major depressive disorder (MDD) treated with selective serotonin reuptake inhibitor (SSRI) and its association with serotonin 2A-1438 G/A single nucleotide polymorphisms.Semantic proximity Read ↗

Sexual dysfunction during treatment with serotonergic and noradrenergic antidepressants: clinical description and the role of the 5-HTTLPR.Semantic proximity Read ↗

Association between 5HT2A polymorphism and selective serotonin re-uptake inhibitor (SSRI)-induced sexual desire disorder (SDD) among Malaysian women.Semantic proximity Read ↗

Genome-wide association study of SSRI/SNRI-induced sexual dysfunction in a Japanese cohort with major depression.Semantic proximity Read ↗

Association between serotonin 2A receptor (HTR2A), serotonin transporter (SLC6A4) and brain-derived neurotrophic factor (BDNF) gene polymorphisms and citalopram/sertraline induced sexual dysfunction in MDD patients.Semantic proximity Read ↗

Serotonin 2A −1438 G/A and G-Protein Beta3 Subunit C825T Polymorphisms in Patients with Depression and SSRI-Associated Sexual Side-EffectsSemantic proximity Read ↗

Genetic and clinical predictors of sexual dysfunction in citalopram-treated depressed patients.Semantic proximity Read ↗

Risk Phenotypes, Comorbidities, Pharmacotherapy, and Electroconvulsive Therapy (ECT) in a Cohort with Difficult-to-Treat Depression in Comparison to an Unmedicated Control Group.Semantic proximity Read ↗

Pharmacogenetics and pharmacogenomics of sexual dysfunction: current status, gaps and potential applications.Semantic proximity Read ↗

New perspectives in the treatment of body dysmorphic disorderSemantic proximity Read ↗

A case of adolescent lactation due to the drug blonanserinSemantic proximity Read ↗

Discussion on the Relationship Among Sexual Health and Sleep Quality, Depressive Symptoms in Perimenopausal and Postmenopausal WomenSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.